CIK 0001742927
- Non-accelerated filer
- Smaller reporting company
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Sign in to watch- Ticker
- RVPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 408-501-8881
- Business address
- 10080 N WOLFE ROAD, SUITE SW3-200, CUPERTINO, CA, 95014
- Former names
- Tenzing Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +109,150 | 109,150 | ||
| 2026-03-18 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +40,925 | 40,925 | ||
| 2025-02-13 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +519,000 | 519,000 | ||
| 2025-02-13 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +181,500 | 181,500 | ||
| 2024-09-15 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +158,451 | 158,451 | ||
| 2024-09-15 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +77,843 | 77,843 | ||
| 2023-04-25 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +443,000 | 443,000 | ||
| 2023-04-25 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 |
Page 1 of 1 · 8 trades